Superintelligence guiding existing cancer therapies could beat new drug approvals
hardimanjames · x · 2026-11-01
Anir Jain argues superintelligence's most impactful use in oncology may be guiding existing cancer therapies: predicting responders vs non-responders with current treatments could improve outcomes more than new drug approvals. Valar Labs is working in this space.
More from AGI Musings
- We are already governed by AI to some extent, says Jarovsky — LuizaJarovsky · 2026-11-01
- Cyberpunk creator Mike Pondsmith: an ASI could serve humanity with 10% of its compute — Akumetsu_971 · 2026-11-01
- Ramayana's 6-Year Handcrafted Art Pushback Ignites AI Slop Debate — vishalmisra · 2026-11-01
- At least the cyber apocalypse is arriving before humanoid robots scale — mimi10v3 · 2026-11-01
- The case for everyone running their own local LLM, from a liberal perspective — SoloGen · 2026-11-01
- Only a few hundred people truly know B-rep/CAD geometry kernels, and most are retiring — rms80 · 2026-11-01